Fidelity Investments’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Fidelity Investments’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-50	Closed	-$1K	–	4744
2020 Q4	$1K	Buy	+50	New	+$581	﹤0.01%	3774
2020 Q3	–	Sell	-675	Closed	-$9K	–	4144
2020 Q2	$9K	Buy	+675	New	+$7K	﹤0.01%	3150
2018 Q4	–	Sell	-131,531	Closed	-$2.46M	–	4348
2018 Q3	$2.46M	Buy	131,531 +31	+0%	+$712	﹤0.01%	2326
2018 Q2	$3.4M	Hold	131,500	–	–	﹤0.01%	2233
2018 Q1	$2.95M	Sell	131,500 -111,800	-46%	-$2.73M	﹤0.01%	2296
2017 Q4	$6.09M	Buy	+243,300	New	+$5.96M	﹤0.01%	2111
2015 Q1	–	Sell	-1,303,587	Closed	-$26.3M	–	2815
2014 Q4	$26.3M	Buy	+1,303,587	New	+$23.6M	﹤0.01%	1620
2014 Q2	–	Sell	-170,606	Closed	-$2.81M	–	2818
2014 Q1	$2.81M	Buy	+170,606	New	+$2.95M	﹤0.01%	2316

Other funds holding FLXN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Fidelity Investments's FLXN Position: Q1 2021 in Review

Fidelity Investments sold out of Flexion Therapeutics, Inc. (FLXN) in Q1 2021, closing a stake of 50 shares — an estimated $1K sold.

Fidelity Investments first reported a position in FLXN in Q1 2014 and held it in 8 quarters. The position peaked at $26.3M in Q4 2014. 145 funds tracked by Wall St. Rank hold FLXN as of Q1 2021.

Fidelity Investments reported no remaining Flexion Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
Fidelity Investments sold 50 Flexion Therapeutics, Inc. shares in Q1 2021, an estimated $1K.
Fidelity Investments first reported a position in Flexion Therapeutics, Inc. in Q1 2014 and held it in 8 quarters.
Fidelity Investments's Flexion Therapeutics, Inc. position peaked at $26.3M in Q4 2014.
145 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2021.

Based on Fidelity Investments's 13F filing for Q1 2021, filed 14 May 2021.